Scope
Description
The trust was successful in obtaining a grant from NIHR for a clinical trial to look at the use of metformin in people newly diagnosed with psychosis. The clinical trial (including the recruitment phase) is estimated to take place between June 2026 to November 2028. As part of that grant we need to source a supplier that has the capability to purchase or manufacture Metformin and an identical placebo for a clinical trial, to package and label both to our requirements and distribute to Trusts across the UK in a predetermined schedule.
Total value (estimated)
- £248,333.33 excluding VAT
- £298,000 including VAT
Above the relevant threshold
Contract dates (estimated)
- 17 October 2025 to 16 October 2028
- Possible extension to 16 October 2031
- 6 years
Description of possible extension:
Three optional 12 month extensions
Main procurement category
Services
Additional procurement category
Goods
CPV classifications
- 73300000 - Design and execution of research and development
Contract locations
- UK - United Kingdom
Participation
Legal and financial capacity conditions of participation
Detailed within the specification and Questionnaire 1 - Supplier Information Questionnaire.
Technical ability conditions of participation
Detailed within the specification and Questionnaire 1 - Supplier Information Questionnaire.
Submission
Enquiry deadline
20 August 2025, 12:00pm
Tender submission deadline
5 September 2025, 11:59pm
Submission address and any special instructions
Please download the tender documents, complete and upload back into the E-tendering portal.
https://health-family.force.com/s/Welcome
User Guide:
Tenders may be submitted electronically
Yes
Languages that may be used for submission
English
Award decision date (estimated)
3 October 2025
Award criteria
| Name | Type | Weighting |
|---|---|---|
| Technical Questionnaire | Quality | 60.00% |
| Commercial Questionnaire | Price | 30.00% |
| Social Value Questionnaire | Quality | 10.00% |
Other information
Payment terms
The payment profile for this Contract shall be monthly in arrears.
Invoices to be submitted to the following email address:
Description of risks to contract performance
The Contracting Authority may require an extension of the contract beyond the optional extension periods if the clinical trial is expected to exceed the maximum term stated in the agreement. As this cannot be anticipated in advance, if necessary, it will require a formal contract modification.
The Contracting Authority reserves the right to terminate the clinical trial early for various reasons, including but not limited to insufficient participant recruitment, safety concerns, regulatory requirement concerns, or funder stipulations. In the event that the trial concludes earlier than originally anticipated, this contract may be terminated in accordance with Clause 23.1 (Termination for Convenience) in the contract. In such circumstances, the Contracting Authority shall not be liable for any payments beyond the effective date of termination, and no further financial obligations shall arise under the terms of this contract.
Conflicts assessment prepared/revised
Yes
Procedure
Procedure type
Open procedure
Contracting authority
Pennine Care NHS Foundation Trust
- Public Procurement Organisation Number: PWWC-1379-XVNG
225 Old Street
Ashton-Under-Lyne
OL6 7SR
United Kingdom
Region: UKD35 - Greater Manchester South East
Organisation type: Public authority - central government